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Key messages
 ► How to improve the selection of candidates for lung 
cancer screening.
 ► Data- driven, multivariable predictive models, when 
trained with state- of- the- art methods in statistics 
and machine learning, seem to outperform existing 
criteria sets based on age, pack year and quit time 
cut- off values. This study supports the use of the 
HUNT Lung Cancer Model for selection based on risk 
ranking rather than NLST and NELSON criteria.
 ► The study is the first to compare a prediction mod-
el performance with the NELSON study criteria and 
shows that selection for lung cancer screening can 
be significantly improved.
AbstrAct
Hypothesis We hypothesise that the validated HUNT 
Lung Cancer Risk Model would perform better than the 
NLST (USA) and the NELSON (Dutch‐Belgian) criteria in the 
Danish Lung Cancer Screening Trial (DLCST).
Methods The DLCST measured only five out of the 
seven variables included in validated HUNT Lung Cancer 
Model. Therefore a ‘Reduced’ model was retrained in 
the Norwegian HUNT2- cohort using the same statistical 
methodology as in the original HUNT model but based only 
on age, pack years, smoking intensity, quit time and body 
mass index (BMI), adjusted for sex. The model was applied 
on the DLCST- cohort and contrasted against the NLST and 
NELSON criteria.
results Among the 4051 smokers in the DLCST with 10 
years follow- up, median age was 57.6, BMI 24.75, pack 
years 33.8, cigarettes per day 20 and most were current 
smokers. For the same number of individuals selected for 
screening, the performance of the ‘Reduced’ HUNT was 
increased in all metrics compared with both the NLST 
and the NELSON criteria. In addition, to achieve the same 
sensitivity, one would need to screen fewer people by the 
‘Reduced’ HUNT model versus using either the NLST or 
the NELSON criteria (709 vs 918, p=1.02e-11 and 1317 vs 
1668, p=2.2e-16, respectively).
conclusions The ‘Reduced’ HUNT model is superior in 
predicting lung cancer to both the NLST and NELSON 
criteria in a cost- effective way. This study supports the use 
of the HUNT Lung Cancer Model for selection based on risk 
ranking rather than age, pack year and quit time cut- off 
values. When we know how to rank personal risk, it will 
be up to the medical community and lawmakers to decide 
which risk threshold will be set for screening.
IntroductIon
Lung cancer is the leading cause of cancer 
mortality worldwide,1 and early diagnosis is 
paramount for increasing survival. Currently 
two studies have shown survival benefit of 
lung cancer screening; the National Lung 
Screening Trial (NLST) and the Dutch‐
Belgian randomised lung cancer screening 
trial NELSON study (abstract only). The 
NLST was the largest prospective trial showing 
that low- dose high- resolution computed axial 
tomography (CT) scanning versus X- ray of 
heavy smokers (>30 pack years, <15 years 
quit time) ages 55–74 at inclusion time and 
at 6 years of follow- up reduced lung cancer 
mortality by 20%.2 At the World Congress 
of Lung Cancer 2018, the NELSON results 
revealed that CT screening showed a 26% 
reduction in lung cancer deaths at 10 years 
of study follow- up.3 However, an estimated 
26.7% of those who develop lung cancer 
in a general US population fulfil the NLST 
inclusion criteria for CT screening, and for 
the NELSON such an estimation is not avail-
able.4 5
In a current European Union position 
statement recently published in the Lancet 
Oncology, risk stratification is one of the keys 
to ensure the successful implementation of 
future low- dose CT screening programmes in 
Europe.6 Unfortunately, there is no interna-
tional consensus on which criteria or models 
to use for the optimal selection for lung 
cancer screening.
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Several multivariable risk prediction models have 
been proposed to improve the selection of individ-
uals for lung cancer screening.7 In addition to NLST’s 
pack years, quit- time, and age, these models also have 
considered other potential risk factors, such as history 
of respiratory diseases, exposure to occupational dust 
(asbestos, coal, silica), socioeconomic status, body mass 
index (BMI), history of cancer, race, education, forced 
expiratory volume and biochemical parameters (eg, carc-
inoembryonic antigen, alpha- fetoprotein, and C reactive 
protein).8–10 However, these models and corresponding 
studies also have a variety of potential issues such as age 
cut- offs, inclusion of mainly heavy smokers, restricted 
and/or empirical inclusion of predictors and list- wise 
exclusion of cases with missing data, all of which call into 
question the transferability of these models to clinical 
practice.11
To address some of the issues above, we have recently 
developed a validated risk- assessment model, the HUNT 
Lung Cancer Model, analysing data from 58 343 ever and 
never smokers of all ages.11 The model includes seven 
predictors automatically selected based on data- driven 
techniques through backwards feature selection from 
an initial pool of 36 candidate variables. The HUNT 
Lung Cancer Model has been externally validated in 
an independent, prospective dataset containing 45 341 
ever- smokers with a concordance index (C- index) 0.879 
(95% CI 0.866 to 0.891) and with area under the receiver- 
operating- characteristic curve 0.87 (95% CI 0.85 to 0.89) 
for the risk of a lung cancer diagnosis within 6 years. 
Using a 1.75% threshold for the risk to diagnose the 
disease within 16 years, sensitivity was 81.9% and speci-
ficity 78.3%. According to the model, by screening 22% 
of ever- smokers one could identify 81.85% of all lung 
cancers within 6 years and was competitive with the NLST 
criteria for the same number of screenings.11 The model 
is valid for either former or current daily smokers of any 
smoking burden and quit time, and for all of the adult 
population (>20 years old). Another advantage of the 
model is that is does not require knowledge of the history 
of chronic obstructive lung disease (COPD), the history 
of lung X- rays, the family or personal cancer history, or 
the educational history that are often hard to obtain in a 
reliable fashion.
A competitive methodology to the above model, are the 
NLST and NELSON criteria. These sets of criteria lead to 
binary decisions: screen or not screen. In contrast, the 
HUNT Lung Cancer Model ranks individuals according 
to the risk of developing lung cancer. To apply it in a clin-
ical setting, one would need to determine a threshold of 
risk above which to screen individuals. This threshold 
should be determined considering several public heath 
factors, such as the screening capacity, cost of screening, 
and increased risk to the individual due to screening.
The goal of this study is to provide a comparative evalu-
ation of the HUNT Lung Cancer model against the NLST 
and NELSON criteria. To this end, we have selected 
the data from the Danish Lung Cancer Screening Trial 
(DLCST) as it is a large scale, completed screening study, 
with a long- follow up time. Moreover, the DLCST data 
contain five out of the seven variables required by the 
HUNT Lung Cancer Model, unlike other datasets (eg, 
the NLST data). To cope with the issue of the two missing 
variables in DLCST, we have retrained (re- fit) the HUNT 
Lung Cancer Model on the original HUNT2 data using 
only the commonly measured five variables. The resulting 
model is called the ‘Reduced’ HUNT model.
MetHods
dLcst cohort
The DLCST was conducted in Denmark, a prospective 
lung cancer screening trial randomising participants to 
a baseline and four annual CT scans versus no follow- up. 
Between the 1 November 2004 and 31 March 2006, 
a total of 4104 participants (mean age 58 years; 45% 
women) were enrolled, starting with an initial (baseline) 
screening and followed by four annual screening rounds 
and follow- up until 2015.12 All cancers diagnosed were 
histologically or cytologically verified. Participants had 
to be smokers or former smokers with at least 20 pack 
years, less than 10 years quit time and age 50–70. The 
participants also had to be able to walk 36 stair- steps up 
without stopping, and have lung function (forced expir-
atory volume in one second) >30% of predicted. The 
exclusion criteria were; body- weight >130 kg, former 
lung, breast or kidney cancer or malignant melanoma, 
>5 years after treatment for other cancers, symptoms of 
lung cancer (haemoptysis, chest pain, weight loss >6 kg, 
dyspnoea at rest), CT scan within last year or treatment 
for tuberculosis less than 2 years ago.
developing the ‘reduced’ Hunt model based on the Hunt 
Lung cancer Model methodology
The original HUNT Lung Cancer Model was developed 
based on the Nord- Trøndelag Health Study 2 (HUNT2), 
which is a collaboration between HUNT Research Centre 
(Faculty of Medicine and Health Sciences, Norwegian 
University of Science and Technology), Nord- Trøndelag 
County Council, Central Norway Health Authority, and 
the Norwegian Institute of Public Health.
In short, from 1995 to 1997, HUNT2 invited 93 898 
residents of Nord- Trøndelag County in Norway, aged 20 
years or more, to participate in a health survey, and ≈70% 
(n=65 237) responded.13 The data were collected through 
questionnaires on demographic characteristics, medical 
history and lifestyle (199 variables). In 2012, our group 
was granted access to analyse the HUNT2 data to iden-
tify lung cancer cases and establish the HUNT2 discovery 
dataset. This dataset was linked with the national 11- digit 
personal identification number of each participant to 
the Norwegian Cancer and Death Cause Registry. The 
resulting risk prediction model, called HUNT Lung 
Cancer Model included seven variables: age, pack years, 
smoking intensity, years since smoking cessation, BMI, 
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Table 1 The screened and non- screened groups in the DLCST (n=4051) regarding the five variables in the ‘Reduced’ HUNT 
model; sex, age, pack years, BMI, quit time and cigarettes per day (iqd: interquartile distribution). Variables in the screened 
and non- screened population of DLCST
Variables All Screened Non- screened P value
Sex, males (%) 54.70 56.03 54.63 0.3737
Age median (iqd) 57.61 (53.72–61.21) 57.73 (53.66–61.23) 57.45 (53.79–61.20) 0.7836
Pack years median (iqd) 33.75 (27.00–42.00) 34.00 (27.00–42.22) 33.00 (26.25–42.00) 0.2402
BMI median (iqd) 24.75 (22.65–27.27) 24.74 (22.64–27.38) 24.76 (22.66–27.17) 0.7336
Quit time, years median (iqd) 0 (0–0) 0 (0–0) 0 (0–0) 0.1855
Cigarettes per day median (iqd) 20 (15–20) 20 (15–20) 20 (15–20) 0.4665
BMI, body mass index; DLCST, Danish Lung Cancer Screening Trial.
‘daily cough in periods of the year’ and ‘hours of indoors 
smoke exposure’.11
The ideal scenario would be to test the HUNT Lung 
Cancer Model with all seven variables in the Danish 
cohort. However, two variables were not recorded in 
the DLCST, namely ‘daily cough in periods of the year’ 
and ‘hours of indoor smoke exposure’. We therefore 
re- trained a new model to predict lung cancer using the 
remaining five variables; age, pack years, BMI (height 
and weight were given and used for BMI estimation), quit 
years, cigarettes per day, adjusted for sex. This ‘Reduced’ 
HUNT model (named HUNT model hereafter) was 
trained in the HUNT2 subcohort of 12 091 ever- smokers 
aged 50–70 (online supplementary table S1), which 
is the DLCST inclusion age, to ensure applicability to 
the Danish cohort.1 In this HUNT subcohort, 227 lung 
cancers were diagnosed within 10 years follow- up. The 
same statistical methodology as described in Markaki et al11 
was applied, excluding the feature selection step; the five 
variables measured in DLCST were by default included 
in the model. In more detail, the original variables were 
non- linearly transformed whenever necessary, as in the 
original paper; hence pack years, quit- time and BMI 
were logarithmically transformed. Missing values were 
imputed using multiple imputation with predictive mean 
matching (R package mice), resulting in 30 complete 
datasets. For each of them, 200 bootstrap datasets were 
generated for the internal validation of the model using 
R package rms.14 Discrimination power measured by the 
C- index and calibration were assessed as performance 
metrics. In calibration plots, the Hosmer- Lemeshow test 
was used to denote goodness of fit between the predicted 
and observed individual risks. To analyse the model 
with the clinical criteria on equal grounds, we set a risk 
threshold that defines equal number of screenings to the 
ones suggested by NLST or NELSON and compare the 
numbers of false positives and false negatives with the 
χ2 test (p<0.05 deemed significant). The χ2 test was also 
used for comparing percentage of screenings according 
to the HUNT model to achieve the same sensitivity as the 
NLST and NELSON (p<0.05 deemed significant).
To identify a high- risk group, we consider as a high- 
risk individual anybody with a risk score in the top 16 
quantile, as proposed by Royston and Altman and used 
in the original HUNT model study.11 15
nLst and neLson study criteria
The criteria for inclusion in the NLST are the following: 
age 55–74, >30 pack years and <15 years quit time. For 
the NELSON study, the respective criteria are: age 50–75, 
>15 cigarettes a day >25 years, or >10 cigarettes a day >30 
years, 10 or less years quit time. The two sets of criteria 
were enforced on the DLCST to characterise individuals 
as high- risk and predict that they would develop lung 
cancer.
resuLts
dLcst cohort descriptive statistics
The DLCST included 4104 individuals (2052 screened, 
2052 non- screened) where 4051 (98.7%) individuals had 
registered all the five variables required for the HUNT 
model and 149 of 153 (97.3%) lung cancers developed 
in this group. The univariate distributions of each of the 
five measured variables, as well as sex do not significantly 
differ between the screened and non- screened groups 
(table 1).
Performance of the Hunt model on the dLcst cohort
Internal validation in the HUNT2 subset produced a 
C- index=0.783. The C- index metric equals the proba-
bility that the model assigns a higher risk to the person 
that experiences the event first (lung cancer diag-
nosis) between a pair of randomly chosen individuals. 
External validation on the Danish cohort produced a 
lower C- index (total group 0.663, non- screened 0.709, 
screened 0.638). The calibration was reliable for the 
HUNT2 subset (p=0.452) and marginal for the Danish 
cohort (p=0.0681) (online supplementary figure 1). 
This finding is explained by the fact that the HUNT2 
and DLCST have significantly different distributions of 
risk factors (table 2) due to the fact that the DLCST is a 
selected, heavy- smoker population.
Setting as threshold the top 16 quantile risk score 
of the HUNT in the DLCST would have selected for 
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Table 2 Modified Cox- regression model (‘Reduced’ HUNT model) of cancer risk for ever smokers in HUNT2, restricted 
to age 50–70 as in the Danish cohort, with no previous cancer, no cancer at inclusion and 10 years follow- up (n=12 091). 
Body mass index, pack years and smoking quit time had a non- linear association with lung cancer, and these variables were 
logarithmically transformed
Variable P value Beta coefficient (95% CI) SE
Age <0.0001 0.0682 (0.0458 to 0.0905) 0.0114
Sex 0.7514 0.0479 (−0.2304 to 0.3262) 0.1420
Body mass index (log) 0.0017 −1.4879 (−2.4409 to 0.5350) 0.4862
Smoking intensity 0.0469 −0.0331 (−0.0623 to 0.0039) 0.0149
Pack years (log) <0.0001 1.2066 (0.8150 to 1.5982) 0.1998
Smoking quit time (log) 0.0011 −0.2667 (−0.4235 to 0.1099) 0.0800
Figure 1 Cartoon of Danish Lung Cancer Screening Trial, screened and non- screened population in total (n=4051, 149 
diagnosed cancers). Sensitivity (upper) and cancers ‘lost’ (lower) using the ‘Reduced’ HUNT model, the NELSON and the 
NLST criteria (p values for comparing proportions were by χ2 test, p<0.05 deemed significant).
screening 148 out of the 149 individuals that developed 
lung cancer (sensitivity 99.3%, specificity 3.31%, positive 
predictive value (PPV) 3.77%, negative predictive value 
(NPV) 99.23%, figure 1, table 3).
comparison of the Hunt model against the nLst criteria
According to the NLST criteria less than half of the 
Danish cohort 1870/4051 (46.2%) would be considered 
eligible for screening. Among those selected, 104/149 
cases would have been identified for screening (sensi-
tivity 69.80%, p=1.54e-14, in favour of HUNT, figure 1, 
table 3).
As mentioned, the NLST criteria provide binary deci-
sions (screen, not screen), while the HUNT model ranks 
individuals according to predicted risk. To compare the 
model with the clinical criteria on equal grounds, we set 
a risk threshold that defines equal number of screenings 
to the ones suggested by NLST. Hence, for the same 
number of individuals screened (n=918) suggested by 
NLST in the non- screened DLCST cohort (n=1 999), 
the HUNT model showed increased predictive perfor-
mance in all metrics: sensitivity, specificity, PPV and NPV 
(table 4). In addition, for a risk threshold of the HUNT 
model so that the sensitivity achieved (percentage of 
detected cases out of all cases) equals the sensitivity of 
the NLST criteria, the number of suggested screenings 
by the HUNT model is significantly lower: 709 screenings 
for the HUNT model versus 918 screenings for the NLST 
(p=1.02e-11, figure 2).
comparison of the Hunt model against the neLson criteria
The NELSON study age criterion was 50–75 but had two 
sets of smoking criteria; >15 cigarettes a day >25 years, 
≤10 years quit time (here called NELSON1), or >10 ciga-
rettes a day >30 years, ≤10 years quit time (here called 
NELSON2). By using the NELSON1 in the whole DLCST 
2360/4051 (58.25%) people were selected for screening 
resulting in 109/149 (sensitivity 73.15%) cancers being 
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Table 3 Performance of the ‘Reduced’ HUNT model versus NLST and NELSON criteria based on the whole cohort (n=4051). 
The threshold used in the model to decide screening for lung cancer is the 16% quantile of risk of events in the HUNT cohort 
with complete data. sensitivity is significantly higher for the HUNT model versus the NLST (p=1.54e-14) and versus the 
NELSON (p=0.018), but the specificity is lower (figure 1)
LC (n) Without LC (n) Total (n) Predictive value
Population 149 3902 4051
  ‘Reduced’ HUNT*
  Criteria positive 148 TP (3.77%) 3773 FP (96.23%) 3921 PPV 3.77%
  Criteria negative 1 FN (0.77%) 129TN (99.23%) 130 NPV 99.23%
  Sensitivity 99.33%
  Specificity 3.31%
NLST†
  Criteria positive 104 TP (5.56%) 1766 FP (94.44%) 1870‡ PPV 5.56%
  Criteria negative 45 FN (2.06%) 2136 TN (97.94%) 2181 NPV 97.94%
  Sensitivity 69.80%
  Specificity 54.74%
NELSON§
  Criteria positive 141 TP (4.08%) 3449 FP (96.07%) 3590 PPV 4.08 %
  Criteria negative 8 FN (1.71%) 461 TN (98.29%) 469 NPV 98.29%
  Sensitivity 94.63%
  Specificity 11.79%
  NELSON2¶
  Criteria positive 141 TP (4.20%) 3209 FP (95.79%) 3350 PPV 4.20 %
  Criteria negative 8 FN (1.14%) 693 TN (98.29%) 701 NPV 98.85%
  Sensitivity 94.63%
  Specificity 17.76%
*‘Reduced’ HUNT model criteria.
†NLST criteria (: >30 pack years of smoking, <15 years since quitting and ages between 55 and 74 years).
‡Total criteria positive selected by the ‘Reduced’ HUNT model includes those picked by the NLST.
§NELSON criteria age 50–75, >15 cigarettes a day >25 years, or >10 cigarettes a day >30 years, both with 10 or less years quit time.
¶NELSON2 criteria >10 cigarettes a day >30 years, both with 10 or less years quit time.
FN, false negative; FP, false positive; NPV, negative predictive value; PPV, positive predictive value; TN, true negative; TP, true positive.
predicted. The NELSON2 criteria would select 3350/4051 
(82.69%) people for screening detecting 141/149 (sensi-
tivity 94.73%) cancers. The NELSON criteria, which 
is the union of the NELSON1 and NELSON2 criteria, 
would select 3590/4051 (88.62%) people for screening 
predicting 141/149 cancers (sensitivity 94.73%, p=0.018, 
in favour of HUNT) (table 3, figure 1)).
To compare the NELSON criteria to the HUNT model 
on equal grounds we follow the same methodology 
described above. When the risk- threshold is set so that 
the two models suggest the same number of screenings 
(n=1 668), the HUNT model outperforms the NELSON 
criteria in all metrics, namely sensitivity, specificity, PPV 
and NPV (table 5). In addition, for a risk threshold of the 
HUNT model so that the sensitivity achieved (percentage 
of detected cases out of all cases) equals the sensitivity 
of the NELSON criteria, the HUNT model requires the 
screening of a significantly smaller number of individ-
uals, namely 1317 versus 1668 for the NELSON (p=2.2e-
16, figure 2).
dIscussIon And concLusIons
The optimal selection of a high- risk population for lung 
cancer screening is still an unsolved issue. For example, 
simple age and smoking criteria, like the NLST, would 
fail to screen two- thirds of smokers that develop lung 
cancer.3
In this study, we used the validated 7- variable HUNT 
Lung Cancer Model to develop and apply a 5- variable 
‘Reduced’ HUNT model, based on the five available vari-
ables in the Danish screening trial. This downgraded- to-
5- variables, reduced model outperforms cut- off criteria 
such as the NLST and the NELSON. In addition, it 
outperforms these criteria on the high- risk subpopula-
tions for which they were developed.
comparison of the ‘reduced’ Hunt model with the nLst and 
neLson
The DLCST cohort was a high- risk cohort by itself and 
improving the selection further represented a difficult 
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Table 4 Direct comparison of the ‘Reduced’ HUNT model against NLST criteria, for the same number of individuals as 
selected by the NLST (n=918), on the control group of DLCST (n=1999). The HUNT model shows increased predictive 
performance in all metrics (sensitivity, specificity, PPV, NPV)
LC (N) Without LC (N) Total (N) Predictive value
Population 52 1 947 1999
‘Reduced’ HUNT
  Criteria positive 40 TP (4.36%) 878 FP (95.64%) 918† PPV 4.36%
  Criteria negative 12 FN (1.11%) 1069 TN (98.89%) 1081 NPV 98.89%
  Sensitivity 76.92%
  Specificity 54.90%
NLST‡
  Criteria positive 35 TP (3.81%) 883 FP (96.19%) 918* PPV 3.81%
  Criteria negative 17 FN 1.57% 1064 TN 98.43% 1081 NPV 98.43%
  Sensitivity 67.31%
  Specificity 54.65%
‘Reduced’ HUNT model.
*‘Reduced’ HUNT model criteria.
†The number of those picked by the NLST, but with the top risk score by the ‘Reduced’ HUNT model.
‡NLST criteria (: >30 pack years of smoking, <15 years since quitting and ages between 55 and 74 years).
FN, false negative; FP, false positive; NPV, negative predictive value; PPV, positive predictive value; TN, true negative; TP, true positive.
Figure 2 Comparison of persons needed screening by the 
‘Reduced’ HUNT model to obtain same sensitivity as the 
NLST or NELSON in the unscreened population (n=1 999) 
(p values for comparing proportions were by χ2 test, p<0.05 
deemed significant).
task. Despite of the participants’ relative young age 
(median 57 years), they had high pack year counts 
(median 33.75) and were mostly current smokers that are 
known to have a higher risk than former smokers (zero 
quit time, table 1). When the models are compared on 
equal grounds (same number of individuals to screen) 
the HUNT model outperforms both the NLST and the 
NELSON in all performance metrics employed (tables 4 
and 5).
Moreover, in equal footing (to gain the same sensitivity 
as the NELSON or NLST) one would need screening 
26.6% more people using the NELSON and 29.4% more 
people using the NLST criteria than the HUNT risk 
ranking (see Results section and figure 2). Sparing >25% 
of a heavy smoker population of screening designated 
as high- risk by NELSON and NLST criteria by using this 
model could be considered cost effective. Given that the 
predictive performance of the HUNT model is superior 
in all metrics than the NLST and the NELSON criteria, 
implies that it is the most cost- effective of the three for a 
given risk threshold.
As we noted in our previous HUNT paper, and 
according to the original HUNT model, in a low- smoking 
population, one would need to screen only 22% of ever- 
smokers to identify 81.85% of all lung cancers within 6 
years.11 In this highly selected cohort, using the same 
threshold excludes very few from screening (3.2%) and 
identifies almost the whole DLCT cohort as high- risk, 
which is logical, since most were heavy smokers and 
current smokers. However, it predicts 149 out of 150 
cases, 99.3%.
In contrast, applying the NLST selection criteria on the 
DLCST cohort is so strict that 53.8% of this population 
would be excluded and one would fail to screen 40.2% of 
the cases within this cohort (figure 1, table 3). Similarly, 
applying the NELSON study criteria on the DLCST, one 
would exclude from screening 17.4% of the population 
failing to identify 5.3% of the cancer cases (table 3).
A major difference between the HUNT model and 
fixed criteria sets, like the NELSON and the NLST, is that 
the former produces a ranking of individuals according 
to risk. To decide which individuals to screen, one needs 
to set a risk threshold above which screening should 
take place. The threshold should be set in the most cost- 
effective way, as a consensus, considering all public health 
factors (eg, screening capacity, risk due to screening, 
predictive performance of the model).
One may question whether these models are developed 
in a population with a representative spectrum of all lung 
cancer subtypes. The cancer subtypes in the DLCST were 
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Table 5 Direct comparison of the ‘Reduced’ HUNT model against NELSON criteria, for the same number of individuals 
(n=1668), on the control group of DLCST. The HUNT model shows increased predictive performance in all metrics (sensitivity, 
specificity, PPV, NPV)
LC (N) Without LC (N) Total (N) Predictive value
Population 52 1 947 1999
‘Reduced’ HUNT*
  Criteria positive 50 TP (3.00%) 1618 FP (97.00%) 1668† PPV 3.00%
  Criteria negative 2 FN (0.60%) 329 TN (99.40%) 331 NPV 99.40%
  Sensitivity 96.15%
  Specificity 16.90%
NELSON‡
  Criteria positive 47 TP (2.82%) 1621 FP (97.18%) 1668* PPV 2.82%
  Criteria negative 5 FN (1.51%) 326 TN (98.45%) 331 NPV 98.45%
  Sensitivity 90.38%
  Specificity 16.74%
‘Reduced’ HUNT model.
*‘Reduced’ HUNT model criteria.
†The number of those picked by the NELSON, but with the top risk score by the ‘Reduced’ HUNT model.
‡NELSON criteria age 50–75, >15 cigarettes a day >25 years, or >10 cigarettes a day >30 years, both with 10 or less years quit time.
FN, false negative; FP, false positive; NPV, negative predictive value; PPV, positive predictive value; TN, true negative; TP, true positive.
previously published and include the whole spectrum of 
lung cancers, including 38% adenocarcinoma, 15% squa-
mous cell lung cancer, 15% non- small cell lung cancer, 
14% small- cell lung cancer and the rest broncho- alveolar 
carcinoma, large- cell carcinoma and combinations of 
histologies.12 The original HUNT model was based on a 
population of >65 000 age 20–100 and since it was unse-
lected, indeed cover the whole spectrum of lung cancer 
subtypes. Both HUNT models are therefore suitable for 
all types of lung cancers.
comparison of Hunt with the PLcom2012 model
The five variables in this HUNT model were also found 
in another high- performing model, the PLCOm2012 that 
consists of 10 variables, including COPD, family history of 
lung cancer and educational status.16 The PLCOm2012 was 
also found more sensitive than the NLST criteria in the 
NLST study, and showed how ranking of risk is superior 
to fixed criteria, like in our study. However, in contrast to 
the original HUNT model the PLCOm2012 was developed 
in a population of age 55–74 and with a mean pack year 
count of ≈30 high, and thus light smokers with many years 
of smoking, people younger than 55 or older than 74 and 
as well as combinations of all those are not represented.11 
Moreover, there are two variables used in the PLCOm2012 
that are susceptible to bias, namely ‘history of COPD’ and 
‘family history of lung cancer’, correspondingly reflected 
in biassed predictions. Specifically, in the case of COPD, 
misdiagnosis is very common : under- and over- diagnosis 
can be fivefold more common than correct diagnosis.17 
Similarly, ‘family history of lung cancer’ is also a variable 
that may be hard to obtain accurately as some people 
may not know details of their family history due to several 
reasons, such as estrangement, death, or adoption from 
unknown donors.16 18 Some studies showed that about 
one- quarter of those who had blood relatives with cancer 
documented in medical records did not report a family 
history. Such studies demonstrate the weakness and 
potential danger of transferring a population- based risk 
factor to a personal risk prediction model.19 20
study limitations
The present study, analysis, and model exhibit several 
limitations. The original HUNT Lung Cancer Risk 
Model was developed in a total adult population of all 
degrees of smoking burden with 199 clinical variables to 
choose among, an ideal population to learn which are 
true, independent and interdependent risk factors.11 
Out of the 199 variables, 36 were manually selected based 
on expert knowledge; the data- driven feature selection 
ended up with seven clinical variables, out of which five 
were employed in the HUNT model presented here. The 
manual feature selection was performed so that the Cox 
model had enough statistical power to enable a back-
ward feature selection methodology. However, one could 
potentially employ other feature selection method, more 
suitable to high- dimensional data, to perform feature 
selection directly with the original set of the 199 varia-
bles, possibly leading to better predictive models. In addi-
tion, other modelling techniques could be employed to 
try to improve the predictive power, for example, using 
Random Survival Forests, Support Vector Machines for 
censored time- to- event outcomes, and others.
To apply the HUNT model to a clinical setting, as 
mentioned above, one should choose a risk threshold 
for defining the high- risk population to screen. Such 
a threshold is not trivial to determine as it depends on 
several factors and public health issues.
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A shortcoming of the present study is that the DLCST 
lacked two variables of the original HUNT model, 
namely, periodical daily cough and hours of exposure 
to indoor smoke. Thus, the current study serves only as 
a proxy of a direct comparison of the original HUNT 
model with the NLST and the NELSON criteria. Never-
theless, it is reasonable to expect that the inclusion of 
these extra sources of information would prove benefi-
cial and not detrimental to the predictive power of the 
model.
Moreover, as much as we would like to compare the 
PLCOm2012 model against the HUNT model on the 
Danish cohort, unfortunately, this is not possible as 
the PLCOm2012 model requires variables not measured 
in that cohort. Specifically, the variables needed for 
the PLCOm2012 model not included in the Danish trial 
are: race, education, COPD yes/no, personal history 
of cancer yes/no, family history of lung cancer yes/no. 
Nevertheless, an aggregate comparison between the orig-
inal HUNT model and the PLCO, that is, a comparison 
on their average predictive metrics and not individual 
predictions on the same cohort, was performed in the 
HUNT original paper in EBiomedicine.11
Regarding the cohorts used in this study, both the 
training data (HUNT cohort) and the validation data 
(DLCST) are of European ancestry; it is thus untested, 
how well the model generalises to populations of other 
ancestries such as, African, Asian and South Amer-
ican that are under- represented in both cohorts. The 
generalisation of the model to populations that are 
either genetically or socially (lifestyle) quite different 
deserves further study. In addition, the training cohort 
lacked some quantities, not included in our original 36 
considered variables. Clinical quantities such as signif-
icant comorbidities and employment exposures could 
possibly improve the predictive power of the model. 
Of course, molecular measurements could provide a 
wealth of predictive information that is not employed 
in the current work.
concLusIons
The HUNT model outperforms the NLST and the 
NELSON criteria in all predictive performance metrics, 
as demonstrated on the DLCST study, a screening trial 
in Denmark with a 10- year follow- up period. Unlike 
cut- off criteria regarding age, pack years and quit time, 
a risk prediction model ranks individuals according to 
a weighted average of many variables, permitting the 
medical community and public health authorities to 
determine the risk threshold that is most cost- effective 
for screening. This is the first study that directly compares 
favourably against the NELSON criteria. The results 
support the original HUNT Lung Cancer Model and indi-
cate that this should be used prospectively in a screening 
study or programme. Data- driven, multivariable predic-
tive models, when trained with state- of- the- art methods 
in statistics and machine learning, seem to outperform 
current criteria and provide a potentially fruitful research 
direction that could be clinically important. Our hope is 
that public health authorities will consider this fact when 
determining screening guidelines.
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